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Abstract
Background: With the increasing number of people participating in physical aerobic exercise,
jogging in particular, we considered that it would be worth knowing if there are should be limits to
the exercise with regard to the intraocular pressure (IOP) of the eyes. The purpose of this study
is to check IOP in healthy and primary glaucoma patients after aerobic exercise.
Methods: 145 individuals were subdivided into seven groups: normotensives who exercised
regularly (Group A); normotensives in whose right eye (RE) timolol maleate 0.5% (Group B),
latanoprost 0.005% (Group C), or brimonidine tartrate 0.2% (Group D) was instilled; and primary
glaucoma patients under monotherapy with β-blockers (Group E), prostaglandin analogues (Group
F) or combined antiglaucoma treatment (Group G) instilled in both eyes. The IOP of both eyes was
measured before and after exercise.
Results: A statistically significant decrease was found in IOP during jogging. The aerobic exercise
reduces the IOP in those eyes where a b-blocker, a prostaglandin analogue or an α-agonist was
previously instilled. The IOP is also decreased in glaucoma patients who are already under
antiglaucoma treatment.
Conclusion: There is no ocular restriction for simple glaucoma patients in performing aerobic
physical activity.
Background
As an increasing number of people are becoming active in
aerobic physical exercise such as jogging and bicycling it
would be interesting to identify any limitations or precau-
tions, concerning the effect of exercise on intraocular pres-
sure (IOP). Previous studies have shown a reduction in
IOP following certain forms of exercise, ranging from
walking to exhausting exercise, in healthy volunteers.
According to Qureshi et al all forms of physical exercise
(bicycling, walking and jogging) decrease IOP [1]. It is
also well known that intraocular pressure decreases after
severe exercise to exhaustion [2]. However, the effect of
exercise on the IOP for individuals under antiglaucoma
medication has not been extensively studied. The present
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in athletes, non athletes and glaucoma patients that per-
form jogging or bicycling with or without instillation of
various antiglaucoma eye drugs. The study dealt with this
issue using a significant number of individuals (totally
145 individuals) including normotensive individuals and
glaucoma patients.
Methods
One hundred healthy individuals and forty-five primary
(open-angle) glaucoma patients were included in the
study. This study was approved by the local Ethics Com-
mittee of our University and all patients signed an
informed consent before the start of the trial. Each subject
also underwent a preliminary ophthalmologic examina-
tion before participating in the study. The healthy individ-
uals had no history of ocular or systematic diseases and
were not under any topical or systemic medication. All
glaucoma patients suffered from primary open angle glau-
coma (POAG) and were under various antiglaucoma eye
drops while four of them suffered from hypertention and
were receiving appropriate treatment.
Glaucoma patients and healthy individuals were divided
into seven groups (demographic data shown in Table 1):
Group A consisted of 25 normotensive individuals who
exercised regularly. In those subjects just after the comple-
tion of 20 minutes of sub-maximal (70%) aerobic exercise
(jogging) the IOP on both eyes was measured again. There
was no instillation of any drug in their eyes.
Group B consisted of 40 normotensive individuals. All
the subjects in this group had their right eye instilled with
timolol maleate (β-blocker) 0.5%.
Group C consisted of 20 normotensive individuals. All
the subjects in this group had their right eyes instilled with
latanoprost (prostaglandin analogue) 0.005%.
Group D consisted of 15 normotensive individuals. All
the subjects in this group had their right eyes instilled with
brimonidine tartrate (α-agonist) 0.2%.
Group E consisted of 15 POAG patients who were under
monotherapy with timolol maleate (β-blocker) in both
eyes.
Group F consisted of 15 POAG patients who were under
monotherapy with latanoprost (prostaglandin analogue)
in both eyes.
Group G consisted of 15 POAG patients. Thirteen patients
received a combination of two anti-glaucoma drugs
(latanoprost + timolol maleate or timolol maleate + dor-
zolamide or timolol maleate + brimonidine) and two out
of the 15 received a combination of three drugs. (latano-
prost + timolol maleate + dorzolamide or timolol maleate
+ dorzolamide + brimonidine).
The IOP of both eyes was measured before exercise (Gold-
mann applanation tonometry) and was measured again 2
hours after the instillation of the eye drops. Only in case
of Group F the IOP was measured after 12 hours in order
to measure the IOP under the influence of both exercise
and drug therapy. Within 3 minutes after the second
measurement, the individuals were asked to start the exer-
cise on a bicycle ergometer (about 10 minutes of duration
at 60–80 Watts, in accordance to the preference of each
individual so as to perform a moderate-sub maximal-exer-
cise). The IOP of both eyes was measured again within 5
Table 1: Demographics data of participants individuals.
Group male female Age/Mean age total
A normotensive no medication was instilled 16 9 13–18/15.5 25
B normotensive b-blocker in RE 24 16 20–51/35,9 40
C Normotensive prostaglandin analogue in RE 18 2 27–55/36,7 20
D normotensive a-agonist in RE 10 5 17–38/28,7 15
E primary glaucoma under b-blockers 8 7 47–78/62,5 15
F primary glaucoma under prostaglandin analogues 7 8 50–75/61 15
G primary glaucoma under combination of anti-glaucoma drugs 5 10 50–78/64 15
Total 145
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ergometer. In Groups E, F and G, blood pressure and heart
rate were measured 5 minutes before and 5 minutes after
the exercise using the Critikon/Dianamap (Vital Signs
Monitor 8100T) device. Taking into account the fact that
blood pressure and heart rate (HR) tend to increase during
exercise, the individuals were instructed to decelerate the
exercise when their pulse rates increased over 110/minute.
Blood pressure and HR were measured using a non-inva-
sive method (automatic dynameter). Every IOP measure-
ment was performed at least twice and in case of more
than a 2 mmHg difference a third measurement was per-
formed, finally taking into account the mean of the two
higher values.
All measurements were performed in the morning, from
8:00 to 11:00 a.m. One operator was responsible for
installation of the eye drops while the other operator per-
formed the measurements being blinded to the drug ther-
apy of the patient.
As Group A was the control group, we compared the post-
exercise IOP reduction between healthy individuals and
POAG patients taking into account the right eyes of the
healthy individuals of Groups B and C, where we instilled
the antiglaucoma eye drops (β-blockers or prostaglandin
analogues), and the right eyes of the corresponding glau-
coma patients (Groups E and F). We also compared the
IOP of the right eyes of healthy individuals in Group A
(no drug instillation) with the IOP of the right eyes of
glaucoma patients of Groups E and F (monotherapy with
a β-blocker or a prostaglandin analogue) before and after
exercise. Independent-samples t-tests were used to com-
pare the IOP of these groups of subjects before and after
exercise.
Statistical analysis was made using the SPSS Version 11.5
for Windows. According to our calculation a number of at
least 15 patients per group were needed in order to
achieve a power of 90% with an a-level of 0.05.
Results
The mean IOP of the right and left eyes for all groups
before the instillation of the drops, as well as before and
after exercise are summarized in Table 2, 3, 4, 5, 6, 7 and
8. Pair wise comparisons of the means in the three differ-
ent conditions for the right and left eyes separately,
revealed statistically significant differences (p < 0.05). For
all groups there was no statistically significant difference
(p > 0.05) between the right and left eyes.
An independent-samples t-test was conducted to compare
the IOP reduction after exercise of the right eyes of the
individuals in Group B with the IOP reduction after exer-
cise of the right eyes of the individuals in Group E. There
was a significant difference between IOP reduction in
healthy individuals with a β-blocker instillation in their
right eye (2.13 ± 0.72) and IOP reduction in glaucoma
patients under β-blocker monotherapy (2.6 ± 0.81) after
exercise (t = -2.104, p = 0.04). The magnitude of the dif-
ferences in the means was moderate (eta squared =
0.077).
Then, an independent-samples t-test was conducted to
compare the IOP reduction after exercise of the right eyes
in Group C with the IOP reduction after exercise of the
right eyes in Group F. There was no significant difference
in IOP reduction in healthy individuals with a prostaglan-
din analogue instillation in their right eye (1.85 ± 0.71)
and IOP reduction in glaucoma patients under prostag-
landin analogue monotherapy (2.33 ± 0.82) after exercise
(t = -1.871, p = 0.07). The magnitude of the differences in
the means was moderate (eta squared = 0.095).
Finally we conducted an independent-samples t-test in
order to compare the IOP reduction after exercise of the
right eyes in healthy individuals of Group A (no drug
instillation) with the IOP reduction after exercise of the
right eyes in glaucoma patients of Groups E and F (mon-
otherapy with a β-blocker or a prostaglandin analogue).
There was no significant difference in IOP reduction in
athletes (2.92 ± 1.89) and IOP reduction in glaucoma
patients under β-blocker or prostaglandin analogue mon-
otherapy (2.47 ± 0.81) after exercise (t = 1.114, p = 0.274).
The magnitude of the differences in the means was very
small (eta squared = 0.023).
In Figure 1 is demonstrated graphically IOP alterations
after exercise in all Groups of individuals.
Discussion
The reduction of IOP after exercise has been the subject of
various investigations [3-17]. In normal subjects the
intraocular pressure decreases during exercise [18], and its
reduction is proportional to the work load [19]. In the
present high-powered study we observed that in all groups
there was an IOP reduction after aerobic exercise regard-
less of antiglaucoma eye drop instillation.
Table 2: Group A
IOP RIGHT EYE LEFT EYE
Before exercise 13.36 ± 1.786 mmHg)
(range 10–17 mmHg)
13.16 ± 1.540 mmHg
(range 10–17 mmHg)
After exercise 10.6 ± 2.240 mmHg
(range 7–16 mmHg)
p < 0.05
10.58 ± 2.105 mmHg
(range 8–17 mmHg)
p < 0.05Page 3 of 7
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Table 3: Group B
IOP RIGHT EYE LEFT EYE
Before instillation of timolol maleate 0.5% 15.75 ± 1.46 mmHg
(range 12–18 mmHg)
15.62 ± 1.37 mmHg)
(range 12–18 mmHg)
2 h after instillation of timolol maleate 0.5% 11.92 ± 1.37 mmHg
(range 8–14 mmHg)
13.90 ± 1.28 mmHg
(range 11–16 mmHg)
After exercise 9.80 ± 1.36 mmHg
(range 6–12 mmHg)
p < 0.05
11.65 ± 1.51 mmHg
(range 8–15 mmHg)
p < 0.05
Table 4: Group C
IOP RIGHT EYE LEFT EYE
Before instillation of latanoprost 0.005% 14.08 ± 1.78 mmHg
(range 11–18 mmHg)
14.35 ± 2.10 mmHg
(range 11–20 mmHg)
12 h after instillation of latanoprost 0.005% 11.10 ± 1.79 mmHg
(range 7–14 mmHg)
14.25 ± 1.66 mmHg
(range 11.5–18 mmHg)
After exercise 9.25 ± 1.90 mmHg
(range 5–12.5 mmHg)
p < 0.05
12.13 ± 1.58 mmHg
(range 9–15 mmHg)
p < 0.05
Table 5: Group D
IOP RIGHT EYE LEFT EYE
Before instillation of brimonidine tartrate 0.2% 14.66 ± 2.38 mmHg
(range 9–19 mmHg)
14.06 ± 2.08 mmHg
(range 9–17 mmHg)
2 h after instillation of brimonidine tartrate 0.2% 10.26 ± 2.34 mmHg
(range 6–16 mmHg)
p < 0.05
13.06 ± 2.73 mmHg
(range 7–17 mmHg)
p < 0.05
After exercise 7.4 ± 2.02 mmHg
(range 5–11 mmHg)
10.4 ± 2.55 mmHg
(range 6–15 mmHg)
mean reduction of IOP after the exercise 2.86 ± 2.09 mmHg
p < 0.05
2.66 ± 1.67 mmHg
p < 0.05
Table 6: Group E
IOP RIGHT EYE LEFT EYE
2 h after instillation of b-blocker 17.13 ± 2.39 mmHg
(range 12–20 mmHg)
p < 0.05
16.27 ± 2.31 mmHg
(range 12–19 mmHg)
p < 0.05
After exercise 14.53 ± 2.35 mmHg
(range 10–18 mmHg)
13.73 ± 2.31 mmHg
(range 10–17 mmHg)
mean reduction of IOP after the exercise 2.6 ± 0.81 mmHg
p < 0.05
2.53 ± 1.11 mmHg
p < 0.05
BMC Ophthalmology 2009, 9:6 http://www.biomedcentral.com/1471-2415/9/6Additionally, according to our results, in 40 healthy indi-
viduals there was a further reduction of IOP after aerobic
exercise, regardless of the instillation of a β-blocker uni-
ocularly. Instillation of the β-blocker does not counterbal-
ance the effect of exercise on IOP. Both eyes of the
individuals had lower post-exercise IOP in a similar man-
ner (there was no statistical difference between two eyes).
Similarly, glaucoma patients who were under mono-
therapy with a β-blocker had lower post exercise IOP. We
also noticed a significant difference between IOP reduc-
tion in healthy individuals having a β-blocker instilled in
their right eye (2.13 ± 0.72) and IOP reduction in glau-
coma patients under β-blocker monotherapy (2.6 ± 0.81)
after exercise (t = -2.104, p = 0.04), although the magni-
tude of the mean difference was moderate (eta squared =
0.077). Harris et al [5] also reported that the IOP reduced
in six individuals with the use of a selective β1-blocking
drug (betaxolol) and on seven other individuals with a
non-selective β-blocker (levobunolol) after physical exer-
cise.
The instillation of prostaglandins also does not prohibit
IOP reduction after exercise. As we observed in 20 healthy
individuals, in whom a prostaglandin analogue was
instilled uniocularly, IOP reduction after the aerobic exer-
cise was almost identical in both eyes. The same was
observed in glaucoma patients but there was no signifi-
cant difference in IOP reduction in healthy individuals
with a prostaglandin analogue instillation in their right
eye (1.85 ± 0.71) and IOP reduction in glaucoma patients
under prostaglandin analogue monotherapy (2.33 ±
0.82) after exercise (t = -1.871, p = 0.07). We may assume
that the uveoscleral outflow still increases the aqueous
outflow as a response to the aerobic exercise, despite the
instillation of prostaglandin eye drops. One may assume
that the outflow of aqueous through the trabeculum is
increased or the production of aqueous from the ciliary
processes is lowered as a result of the aerobic exercise.
Similar assumptions can be made on the other antiglau-
coma eye drops we used in the study. The mechanism of
IOP reduction is under constant consideration. Martin et
al demonstrated that acute dynamic exercise seems to alter
IOP through changes in colloid osmotic pressure [10]. A
relationship between increased plasma osmolarity and
IOP reduction was also suggested by Ashkenazi et al. [3]
However, Stewart et al noted that exercise induced greater
changes in IOP than oral doses of glycerin for the same
change in serum osmolarity [16]. Also, Harris et al sug-
gested that the reduction of IOP correlated with the
increase in blood lactate but they did not find any corre-
lation with the plasma osmolarity or the PCO2. A previous
study by Kielar et al noted that blood lactate and pH
changes correlated with intraocular tension changes at
anaerobic exercise levels but they did not correlated with
intraocular tension changes at aerobic exercise levels [10].
Stewart et al also correlated the effect of exercise on IOP
with the nor-epinephrine blood concentration. Lanigan et
al reported IOP responses as a result of systemic auto-
nomic stimulations [9]. Orgul and Flammer reported that
moderate exercise (6 deep knee bents) with a few seconds
of duration can reduce IOP [12]. They correlated this
Table 7: Group F
IOP RIGHT EYE LEFT EYE
12 h after instillation of prostaglandin analogue 15.93 ± 2.31 mmHg
(range 13–19 mmHg)
15.6 ± 2.47 mmHg
(range 13–19 mmHg)
After exercise 13.60 ± 1.80 mmHg
(range 12–16 mmHg)
13.13 ± 2.45 mmHg
(range 11–17 mmHg)
mean reduction of IOP after the exercise 2.33 ± 0.82 mmHg
p < 0.05
2.47 ± 0.52 mmHg
p < 0.05
Table 8: Group G
IOP RIGHT EYE LEFT EYE
After instillation of anti-glaucoma drugs 16.733 ± 2.344 mmHg
(range 12–20 mmHg)
18.50 ± 3.041 mmHg
(range 14.5–25 mmHg)
After exercise 14.267 ± 1.791 mmHg
(range 12–17 mmHg)
p < 0.05
15.667 ± 2.609 mmHg)
(range 12–21 mmHg)
p < 0.05
mean reduction of IOP after the exercise 2.467 ± 1.125 mmHg 2.833 ± 1.248 mmHgPage 5 of 7
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that IOP reduction was the result of sympathetic activity.
In one of our studies, no linear correlations between
blood pressure, heart rate and IOP changes were revealed,
following aerobic exercise in healthy individuals [7].
It has also been suggested that exercise increases the facil-
ity of outflow. The outflow channels of the eye, especially
around Schlemm's canal, show fibrinolytic activity [20].
Such fibrinolysis can be postulated to assist in preventing
obstruction of the aqueous outflow pathways, and thus
aid in the regulation of intraocular pressure. Since exercise
increases systemic fibrinolytic activity [21], one can spec-
ulate that exercise decreases intraocular pressure by facili-
tating outflow, although one study revealed no change in
facility of outflow when measured immediately following
exercise [16].
As for glaucoma patients, regardless of the antiglaucoma
medication instilled, they still benefited from the aerobic
exercise since they all had a post-exercise reduction of
IOP. It is obvious that these patients should be encour-
aged to perform aerobic exercise. Qureshi [14] also exam-
ined 14 individuals (7 normal and 7 glaucoma patients)
and noticed that glaucoma patients had a greater IOP
reduction and longer duration of post-exercise recovery in
comparison to normal individuals. Although the reduc-
tion of IOP after exercise lasts for about one hour, this IOP
reduction is considered beneficial for the eye. Passo et al
[13] in a study of 9 individuals stated that aerobic exercise
is associated with a reduction in increased IOP. In this
study aerobic exercise was suggested as an effective non-
pharmacologic intervention for these individuals. Shapiro
et al also proved that the reduction of the IOP in twelve
simple glaucoma chronic patients under physical exercise
[22]. Our results further confirm that we should encour-
age glaucoma patients to perform aerobic exercise. Still
exercise should be advised with caution for glaucoma
patients suffering from pigmentary [6,11], congenital or
juvenile glaucoma. [15].
There are certain limitations to our study. There is a signif-
icant age difference among the normotensive subjects and
glaucoma patients. This is a result of the nature of the dis-
ease (primary open angle glaucoma) that presents mainly
in elderly people. In any case it has to be pointed out that
the mechanism of the IOP reduction of each antiglau-
coma drug is always the same regardless of age. Also the
mechanism of IOP reduction after prostaglandin ana-
logue requires certain time (1–2 weeks) for the establish-
Graphical demonstration of IOP alterations after exercise in all Groups of individualsFigure 1
Graphical demonstration of IOP alterations after exercise in all Groups of individuals.
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ment of the potency of the drug. However, even a single
instillation of prostaglandin analogues has an IOP lower-
ing effect [23]. All measurements of IOP were performed
seven hours after exercise in order to investigate the com-
bination of prostaglandin analogue plus exercise.
Conclusion
Moderate aerobic exercise reduces the IOP of healthy indi-
viduals (athletes or non athletes). Aerobic exercise also
reduces the IOP following instillation of a β-blocker, a
prostaglandin analogue or an α-agonist. Åxercise reduces
the IOP of glaucoma patients already under antiglaucoma
treatment. Regular moderate aerobic exercise (walking,
jogging, bicycle etc) has been proven beneficial and
should be encouraged for glaucoma patients.
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